EU regulatory authority working for public and animal health. We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam. https://www.ema.europa.eu/https://bsky.app/profile/ema.europa.euhttps://bsky.app/profile/ema.europa.eu/post/3mvrxygii622m📢 EMA recommends: 12 new medicines for approval, including four medicines for cancer. Read more here: 🔗 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2026 #PublicHealth #medsky 🧪 #SciComm18 Sep 2026 10:37 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mvrxygii622mhttps://bsky.app/profile/ema.europa.eu/post/3mvpmdimujc2tDid you know some foods and drinks can affect how your medicine works? 🍊☕🍌 Your package leaflet tells you what to be mindful of, including foods, drinks and alcohol. When in doubt, ask your pharmacist or doctor. Keep safe. Read the leaflet.🧪 #SciComm Learn more: https://www.ema.europa.eu/en/about-us/what-we-do/safety-medicines https://youtube.com/shorts/q5l-IXIojAo?si=kQ19G5npToSmiTzg17 Sep 2026 12:03 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mvpmdimujc2thttps://bsky.app/profile/ema.europa.eu/post/3mvibyyil622rThe agenda of EMA's human medicines committee #CHMP is now published. Find out what medicines will be discussed this month 💊💉 https://www.ema.europa.eu/en/events/committee-medicinal-products-human-use-chmp-14-17-september-2026 The committee highlights will be released on Friday.14 Sep 2026 14:10 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mvibyyil622rhttps://bsky.app/profile/ema.europa.eu/post/3muwjgang3c2uWhat are we doing for women’s health? We’re working to ensure women’s needs are considered in medicine development, evaluation and use, for a wide range of areas: from #endometriosis to #pregnancy and #menopause. Learn more here. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/womens-health #medsky 🧪 #womenshealth07 Sep 2026 12:34 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3muwjgang3c2uhttps://bsky.app/profile/ema.europa.eu/post/3muozq5h34k22We have just started a review of injectable iron-containing medicines following concerns about the risk of low blood phosphate levels and related bone problems. Find out more in #PRAC highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-31-august-3-september-202604 Sep 2026 13:05 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3muozq5h34k22https://bsky.app/profile/ema.europa.eu/post/3muongpqwfc26Good news! A new EU supply chain has been put in place to end the shortage of Visudyne, a medicine used to treat adults with certain serious eye conditions, which will ensure access to patients across the EU. Find out more more: https://www.ema.europa.eu/en/news/new-eu-supply-chain-end-visudyne-shortage04 Sep 2026 09:25 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3muongpqwfc26https://bsky.app/profile/ema.europa.eu/post/3mumlpnepgc2f🎙️ New #InsideEMA episode! What is it like to be an EMA trainee? From regulatory science and policy to learning, networking and life in Amsterdam, current trainees share their experience of working at the European Medicines Agency. 🎧 💊 🌍 https://youtu.be/vnAdvjSmN4E?si=8fmP80sIwBwLgvyr03 Sep 2026 13:49 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mumlpnepgc2fhttps://bsky.app/profile/ema.europa.eu/post/3muhff5aixs2a🚀 We are launching a new voluntary data submission pilot for innovative alternatives to animal testing. Companies can submit data generated using new approach methodologies and receive tailored scientific feedback from EMA 👉 https://www.ema.europa.eu/en/news/voluntary-data-submission-pilot-advance-innovative-alternatives-animal-testing #PublicHealth #medsky 🧪 #SciComm01 Sep 2026 12:12 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3muhff5aixs2ahttps://bsky.app/profile/ema.europa.eu/post/3mtgpinp6422bWhat are the regulatory research priorities for #AI use in the #medicine lifecycle in the EU❓ Find out now from this open-access article: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.70400 #medsky #AIResearch 🧪19 Aug 2026 12:15 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mtgpinp6422bhttps://bsky.app/profile/ema.europa.eu/post/3msxbg32p4c2d“We need to think about strategies to make #vaccination easier, not more complicated,” said Marco Cavaleri, our head of public-health threats, in a Nature article on combined MMR vaccines versus separate #measles, mumps and rubella shots in children. Read more: https://www.nature.com/articles/d41586-026-02515-3 🧪13 Aug 2026 08:53 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3msxbg32p4c2dhttps://bsky.app/profile/ema.europa.eu/post/3msvehw4d5c2lQuestions about childhood vaccination❓Combined measles, mumps and rubella (MMR) vaccines have been used worldwide for several decades to effectively protect children against these diseases. Their safety profile is well-established. Read more: https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/vaccine-preventable-diseases-key-facts/vaccines-concerns-questions-false-claims #medsky 🧪12 Aug 2026 14:43 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3msvehw4d5c2lhttps://bsky.app/profile/ema.europa.eu/post/3msdkdludh223A few days on, we're still reflecting on an unforgettable WorldPride Amsterdam. 🌈 EMA became the first EU agency to join a WorldPride event, sailing with our United for Health boat. Together, we showed that inclusive science makes health better for everyone. 💙 Read more: https://www.ema.europa.eu/en/news-events/ema-campaigns/united-health-worldpride-202605 Aug 2026 12:40 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3msdkdludh223https://bsky.app/profile/ema.europa.eu/post/3mrmssrd2nk2h🎙️ New Inside EMA podcast: Can medicines one day be developed without animal testing? Discover how innovation and the 3Rs (replace, reduce, refine) are helping shape the future of medicines development while protecting patient safety. 🎧 Listen now https://youtu.be/WSnhCV1dtrI?si=uyffD2mRCrVcHMPz27 Jul 2026 11:40 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mrmssrd2nk2hhttps://bsky.app/profile/ema.europa.eu/post/3mrf6mvyhkk2l📢 EMA recommends: 12 new medicines for approval, including one medicine for plaque psoriasis. Read more here: 🔗 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026 🧪 #PublicHealth #medsky #SciComm https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-july-2026#PublicHealth24 Jul 2026 10:50 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mrf6mvyhkk2lhttps://bsky.app/profile/ema.europa.eu/post/3mqtszhhk5c24We're looking for a Clinical Trials Data Management Specialist to join our team in Amsterdam. If you have at least 3 years' relevant experience, and skills in clinical trial data management or statistical programming then apply now! https://careers.ema.europa.eu/job/EMA-Amsterdam-Clinical-Trials-Data-managementStatistical-Programming-Specialist-1143/1400308733/17 Jul 2026 13:07 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mqtszhhk5c24https://bsky.app/profile/ema.europa.eu/post/3mqoo4jty422kInnovation thrives through collaboration. We're strengthening our partnership with EISMEA to support Europe's health innovators. Together, we'll help researchers, start-ups and SMEs bring safe, effective health solutions to patients faster. Read more: https://www.ema.europa.eu/en/news/ema-eismea-boost-cooperation-accelerate-health-innovations15 Jul 2026 11:56 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mqoo4jty422khttps://bsky.app/profile/ema.europa.eu/post/3mqbylwf4422aDuring its meeting in July, our safety committee, the PRAC, agreed new safety information on: 🔹desogestrel- and etonogestrel-containing #contraceptives 🔹Litfulo, a medicine to treat #alopecia areata. #pharmacovigilance #medsky #Scicomm https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-july-202610 Jul 2026 10:59 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mqbylwf4422ahttps://bsky.app/profile/ema.europa.eu/post/3mq2oo3ujdk25EMA fast tracks the review of a #medicine for metastatic pancreatic #cancer, a disease with a high unmet medical need. Read more in our news announcement: https://www.ema.europa.eu/en/news/ema-fast-tracks-review-medicine-metastatic-pancreatic-cancer #medsky #scicomm #pancreaticcancer 🧪07 Jul 2026 13:13 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mq2oo3ujdk25https://bsky.app/profile/ema.europa.eu/post/3mq2abdsams2lThe European Medicines Agency is looking for a Communication Officer to join our team in Amsterdam. If you have at least 2 years' experience in communications, strong writing skills in English and experience in web, media relations or social media, apply now! https://careers.ema.europa.eu/job/EMA-Amsterdam-Communication-Officer-1142/1408900933/07 Jul 2026 08:55 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mq2abdsams2lhttps://bsky.app/profile/ema.europa.eu/post/3mpq3efum622fThis week marked 20 years of EMA’s Patients’ and Consumers’ Working Party – two decades of partnership, progress and patient-centered impact. Since its creation in 2006, it has helped ensure their perspectives are meaningfully reflected in medicines regulation in the EU. Thank you03 Jul 2026 08:01 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mpq3efum622fhttps://bsky.app/profile/ema.europa.eu/post/3mpo4rio2r22dWomen live longer, but often spend more years in poor health. EMA is working to support medicines that are better tailored to women’s needs. Join our Women’s Health Workshop (📆28–29 Sept) and help shape a more inclusive future. #medsky 🧪 #womenhealth https://www.ema.europa.eu/en/news/ema-steps-efforts-medicines-womens-health02 Jul 2026 13:21 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mpo4rio2r22dhttps://bsky.app/profile/ema.europa.eu/post/3mp73o4po3c2e🧪 How does EMA's PRIME scheme help accelerate medicine development? Watch our new video where Kevin Cunningham (EMA PRIME Scientific Coordinator) and Outi Mäkki-Ikola (Finnish Medicines Agency Fimea) explain how PRIME supports innovation and faster patient access to medicines. https://youtu.be/jrEjxoV1APc26 Jun 2026 13:51 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mp73o4po3c2ehttps://bsky.app/profile/ema.europa.eu/post/3mp6rsuoyc222📢 EMA recommends: 6 new medicines for approval, including one medicine for Parkinson's disease. Read more here 🔗 https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-june-2026 #PublicHealth #medsky 🧪 #SciComm26 Jun 2026 10:55 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mp6rsuoyc222https://bsky.app/profile/ema.europa.eu/post/3mox4hntkh22pUp to 90% of pregnant or breastfeeding women use medicines, yet safety data is limited for many treatments. In our latest podcast, EMA’s Corinne de Vries discusses why this gap exists and how we can build better evidence for informed decisions. 🎙️ https://youtu.be/mB0fCRiV918?si=Fy818P7WPdEyPyoK23 Jun 2026 09:44 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mox4hntkh22phttps://bsky.app/profile/ema.europa.eu/post/3mo3ps7o5kk2dWe have just concluded that the evidence of potential risk of neurodevelopmental disorders in children born to men treated with #valproate is inconsistent, so existing precautions should be maintained for male patients. Find out more in #PRAC highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-june-2026 #MedSky 🧪12 Jun 2026 12:15 +0000at://did:plc:4yb5k65ytgx57ggia7cbxju6/app.bsky.feed.post/3mo3ps7o5kk2d